| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008025590A1 Novel use |
| 03/06/2008 | WO2008025115A1 Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions |
| 03/06/2008 | WO2008025114A1 Increasing atp availability by inhibition of creatine kinase (ck) leakage resulting from high-intensity exercise |
| 03/06/2008 | WO2007134867A3 Treating muscular disorders and improving muscular function |
| 03/06/2008 | US20080058425 Ethyl nitrite as a gastrointestinal smooth muscle relaxant and diagnostic and therapeutic uses thereof |
| 03/06/2008 | US20080058423 Melanin concentrating hormone antagonists |
| 03/06/2008 | US20080058324 Alpha-Keto Carbonyl Calpain Inhibitors |
| 03/06/2008 | US20080058298 Blocking hedgehog protein transduction signal passageway using alkaloid steroid |
| 03/06/2008 | US20080058286 Antidiabetic agents, metabolism disorders, cardiovascular disorders, antiinflammatory agents, fertility, muscular disorders, obesity; marine phosphatide |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/05/2008 | EP1894930A1 Thiazole derivative |
| 03/05/2008 | EP1893219A2 Use of spirostenols to treat mitochondrial disorders |
| 02/28/2008 | WO2007033348A3 Process for the synthesis of rocuronium bromide |
| 02/28/2008 | US20080051394 6H-Oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080050352 Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892250A2 CYR61 compositions and methods |
| 02/27/2008 | EP1891949A1 Use of tricyclic indole derivatives for the treatment of muscular atrophy |
| 02/27/2008 | EP1891948A1 Treatment of neurological and neuropsychological disorders |
| 02/27/2008 | EP1891946A1 Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008019825A1 Use of tricyclic indole derivatives for the treatment of muscular diseases |
| 02/21/2008 | WO2008019769A1 Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10- hydroxydecy l)-1,4-benzoquinone |
| 02/21/2008 | US20080045591 (E)-7,7-Dimethyl-1-(4-hydroxy-3-methoxyphenyl)-oct-1-ene-3,5-dione; (E)-1-(4-Hydroxy-3-methoxyphenyl)-6-methyl-hept-1-ene-3,5-dione; prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain |
| 02/21/2008 | US20080045504 Benzonitrile Derivatives to Treat Musculoskeletal Frailty |
| 02/21/2008 | US20080045458 synthetic polypeptides; isolated and purified from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake; encoded from nucleic acid; analgesic or insecticide |
| 02/21/2008 | US20080044410 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement; disorders of insulin metabolism |
| 02/21/2008 | US20080042818 Trailer tire alert system |
| 02/20/2008 | EP1889613A1 Pharmaceutical composition comprising vitamin k |
| 02/20/2008 | EP1888060A2 Nk-b inhibitors for the treatment of muscular dystrophy |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | CN101128578A Method of inducing differentiation of skeletal muscle cell |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | CA2316310C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2007042271A3 Nutraceutical composition for the treatment of muscle wasting |
| 02/14/2008 | US20080039531 Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders |
| 02/14/2008 | US20080039522 Composition Containing a Complex Comprising a Metal Ion and a Carboxylate Ligand Having Anti-Inflammatory Activity |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/13/2008 | EP1886993A1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1303272B1 Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329749 Piperazinylcarbonylquinolines and -isoquinolines |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329511 Nucleic acid encoding GAD65 |
| 02/07/2008 | WO2008016314A1 Myostatin antagonists |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008015484A1 Oily preparation for the alternative therapy of the human musculoskeletal system |
| 02/07/2008 | WO2008015139A2 Inhibitors of zinc proteases thioaryl substituted and their use |
| 02/07/2008 | WO2007073424A8 Pure rocuronium bromide |
| 02/07/2008 | US20080033458 Multi-actuating trigger anchor delivery system |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | CA2693378A1 Myostatin antagonists |
| 02/07/2008 | CA2659336A1 Certain 1h-imidazo[4,5-b]pyrazin-2(3h)-ones and 1h-imidazo[4,5-b]pyrazin-2-ols, compositions thereof and their use |
| 02/06/2008 | EP1884237A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | CN101119951A Modulator |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326730 Aminoadamantane derivatives as therapeutic agents |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 01/31/2008 | WO2008012347A1 Benzo [f] isoindoles as ep4 receptor agonists |
| 01/30/2008 | CN100364558C Application of Korean ginseng extractive in preventing and treating disease of muscular dystrophy |
| 01/30/2008 | CN100364538C Application of fugillin in treating immunity entiritis and related immunity disease |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/24/2008 | WO2008010567A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010566A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010511A1 Screening method |
| 01/24/2008 | WO2008010315A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | WO2008009802A2 Drugs comprising an inhibitor of class 1 alpha mannosidase for the treatment of sarcoglycanopathies |
| 01/24/2008 | WO2006107902A8 Use of spirostenols to treat mitochondrial disorders |
| 01/24/2008 | US20080021051 Phycotoxins and Uses Thereof |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |